Compass Pathways (CMPS), on Wednesday, said the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug application for COMP360, a drug to treat post-traumatic stress ...

The drug is currently classified as a Schedule I controlled substance in the United States, leading those seeking treatment ...

COLUMBUS, Ohio (WCMH) — Ohio lawmakers heard emotional testimony this week from several veterans, each describing how ...

The FDA has accepted an investigational new drug application from a global biotechnology company for its investigational, ...

Vagus-dependent gut–brain signaling inMDMA-induced stress resilience. MDMA elevates central 5-HT and stimulates peripheral release of 5-HT from enterochromaffin cells, alongside oxytocin from ...

Myriam Barthes - Journey Clinical, Inc. Good day, ladies and gentlemen, and welcome to this COMPASS Pathways update webinar. [Operator Instructions] As a reminder, this call is being recorded. I would ...

A University of Idaho lab received $1.3 million from the Department of Defense to study early detection methods for ...

Sisley’s Scottsdale Research Institute has been able to get approval to grow its own marijuana for study—the next cannabis-related work SRI plans is for cancer patients and Phase 2 of the PTSD trials ...

Vagus-dependent gut–brain signaling inMDMA-induced stress resilience. MDMA elevates central 5-HT and stimulates peripheral release of 5-HT from enterochromaffin cells, alongside oxytocin from ...